These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37489076)

  • 1. [Current Status and Prospects of Liquid Biopsy for Hepatocellular Carcinoma].
    Kang J; Kim SS
    Korean J Gastroenterol; 2023 Jul; 82(1):1-9. PubMed ID: 37489076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.
    Lehrich BM; Zhang J; Monga SP; Dhanasekaran R
    J Hepatol; 2024 Mar; 80(3):515-530. PubMed ID: 38104635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
    Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
    Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring.
    Shaik MR; Sagar PR; Shaik NA; Randhawa N
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies for hepatocellular carcinoma.
    Su YH; Kim AK; Jain S
    Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
    Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
    Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
    Mezzalira S; De Mattia E; Guardascione M; Dalle Fratte C; Cecchin E; Toffoli G
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma.
    Lyu X; Tsui YM; Ho DW; Ng IO
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1611-1624. PubMed ID: 35183803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers.
    Yin CQ; Yuan CH; Qu Z; Guan Q; Chen H; Wang FB
    Dis Markers; 2016; 2016():1427849. PubMed ID: 27403030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy.
    Asghar S; Waqar W; Umar M; Manzoor S
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):836-844. PubMed ID: 32312598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies.
    Gonçalves E; Gonçalves-Reis M; Pereira-Leal JB; Cardoso J
    Sci Rep; 2022 Jul; 12(1):11512. PubMed ID: 35798798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.
    Aquino IMC; Pascut D
    Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.
    Weng J; Atyah M; Zhou C; Ren N
    Clin Exp Med; 2020 Aug; 20(3):329-337. PubMed ID: 32239299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
    Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
    J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.